History of actinium

How did our relationship with it begin and change?

André-Louis Debierne found actinium in pitchblende in Paris in 1899 and named it after the Greek word for a ray1. For most of the 20th century it was a subject of research. Since the 1990s it has become a material for cancer medicine.

Last updated 14 October 2026.

Discovery and name

In 1899 André-Louis Debierne found a new radioactive substance in pitchblende. It separated from the ore together with the rare earths1. In 1900 he proposed the name actinium, from the Greek word aktis, a ray1.

In 1902 the German chemist Friedrich Giesel found a substance that he called emanium. Chemists later showed that it was actinium, and Debierne’s name stayed because he was first21. The name had been used before. In 1881 Thomas Phipson gave the name actinium to a metal that he thought was in zinc1.

Sources differ on who isolated actinium first. On its history page, the RSC gives the discovery to Debierne in 18992. In a podcast on the RSC page, the speaker has some doubt about Debierne’s methods and says that Giesel isolated the element clearly by 19042.

In 1935 Arthur Dempster used a mass spectrometer to show that uranium-235 is the parent of the actinium decay series1. In 1945 Glenn Seaborg proposed the actinides, a new row of the periodic table that starts at actinium2.

How our use changed

Research, 1900s to 1980s. For decades actinium was a laboratory material. In 1934 Marie Curie asked Marguerite Perey to prepare the most concentrated actinium sample made up to that time3. In 1938 Perey found that a new substance formed when actinium decays. It was element 87, later named francium3. The 2021 review states that there was almost no production of actinium-227 from the 1970s to the 2010s4.

Actinium-225 for medicine, from the 1990s. In the 1960s the US made uranium-233 at its Hanford Site. Some of the targets went to Oak Ridge, and they also held thorium-2295. In 1994 a team at Oak Ridge started to extract the thorium-229. In August 1997 they made their first shipment of actinium-225, to the National Cancer Institute5.

Approved medicine, 2013. The US Food and Drug Administration approved a radium-223 drug for prostate cancer in 2013. Its radium-223 comes from actinium-2276. Oak Ridge now makes actinium-227 for the drug under a 10-year contract (see the production chapter).

Clinical trials and new supply, from 2016. In 2016 doctors in Heidelberg reported the first patients treated with an actinium-225 drug for prostate cancer7. In 2018 the DOE started regular production with accelerators8. In 2019 the DOE, Isotek and TerraPower agreed to extract thorium-229 from the uranium-233 at Oak Ridge9. In 2024 two large drug companies bought developers of actinium-225 drugs (see the market chapter). In 2025 the DOE announced the first clinical trial that will rely on actinium-225 from accelerators10.

1800s

  1. 1899

    Science

    André-Louis Debierne finds a new radioactive substance in pitchblende in Paris. It separates from the ore together with the rare earths. 1

1900s

  1. 1900

    Science

    Debierne proposes the name actinium, from the Greek word aktis, a ray. 1

  2. 1902

    Science

    Friedrich Giesel finds a radioactive substance that he calls emanium. Chemists later show that it is actinium, and Debierne's name stays. 1

  3. 1934

    Science

    Marie Curie asks her technician Marguerite Perey to prepare the most concentrated actinium sample made up to that time. 3

  4. 1935

    Science

    Arthur Dempster uses a mass spectrometer to show that uranium-235 is the parent of the actinium decay series. 1

  5. 1938

    Science

    While she purifies actinium, Perey finds a new substance that forms when actinium decays. It is element 87, later named francium. 3

  6. 1945

    Science

    Glenn Seaborg formally proposes the actinides, a new row of the periodic table named after actinium. 2

  7. 1994

    Science

    A team at Oak Ridge National Laboratory starts to extract thorium-229 from old uranium-233 targets. Thorium-229 decays to actinium-225. 5

  8. 1997

    Health

    Oak Ridge National Laboratory makes its first shipment of actinium-225, to the US National Cancer Institute. 5

2000s

  1. c. 2004

    Trade

    A Russian institute in Obninsk signs a contract to sell actinium-225 to Isonics, a US company, at 800 US dollars per millicurie. 11

  2. 2013

    Health

    The US Food and Drug Administration approves a radium-223 drug for prostate cancer. Its radium-223 comes from actinium-227. 6

  3. 2016

    Health

    Doctors in Heidelberg report the first patients treated with actinium-225-PSMA-617 for advanced prostate cancer. 7

  4. 2018

    Industry

    The US Department of Energy starts regular production of actinium-225 with proton beams on thorium targets at Brookhaven and Los Alamos. 8

  5. 2018

    Law and policy

    The International Atomic Energy Agency holds a technical meeting on the supply of actinium-225 in Vienna, with 70 participants from 17 countries. 12

  6. 2019

    Industry

    The US Department of Energy reports that Oak Ridge makes actinium-227 for Bayer, under a 10-year contract. 6

  7. 2019

    Industry

    Isotek, TerraPower and the US Department of Energy agree to extract thorium-229 from uranium-233 at Oak Ridge, to make actinium-225. 9

  8. 2021

    Science

    PRISMAP, a European program to supply pure isotopes for medical research, starts. It includes actinium-225 from CERN and Karlsruhe. 4

  9. 2024

    Industry

    Bristol Myers Squibb buys RayzeBio for about 4.1 billion US dollars. RayzeBio's lead drug candidate uses actinium-225. 13

  10. 2024

    Industry

    AstraZeneca completes its purchase of Fusion Pharmaceuticals, a developer of actinium-based drugs, for up to about 2.4 billion US dollars. 14

  11. 2024

    Industry

    TerraPower Isotopes says that it makes actinium-225 at commercial scale, with weekly production runs. 15

  12. 2025

    Health

    The US Department of Energy announces a clinical trial that will be the first to use accelerator-made actinium-225 in patient care. 10

  13. 2025

    Health

    Novartis starts a Phase 3 trial of actinium-225-PSMA-617 for advanced prostate cancer. 16

Sources

  1. 1

    Peter van der Krogt, 2025. Actinium, in Elementymology & Elements Multidict .

    Discovery by Debierne, the name, Giesel's emanium, and Dempster's work on the actinium series.

    • In 1899 André-Louis Debierne (1874-1949) found a radioactive substance which was separated from pitchblende with the rare earths
    • In 1900 he proposed the name Actinium , derived from Greek ακτις [aktis] = ray, sun beam
    • Later was showed that it was identical with Actinium, and since Debierne was earlier, his chosen name took priority.
    • In 1881 Phipson named a metal Actinium . He thought that this metal accompanied Zinc
    • The parent of the series, … and the mass numbers of all its members were established by Arthur Dempster (1886-1950) in 1935, by mass spectrometric analysis.
    • The parent of the series, ... and the mass numbers of all its members were established by Arthur Dempster (1886-1950) in 1935, by mass spectrometric analysis.
  2. 2

    Royal Society of Chemistry, 2025. Actinium, in the Periodic Table .

    Crustal abundance, actinium in pitchblende, production from radium-226, uses, toxicity, discovery and the podcast on the actinides.

    • In 1902, Friedrich Otto Giesel independently extracted it from the same mineral and, unaware it was already known, gave it the named emanium.
    • This element was discovered in 1899 by André Debierne at Paris.
    • there is some doubt as to whether his techniques had actually allowed the element to be properly identified
    • by 1904, had unambiguously isolated it
    • In 1945, Seaborg formally proposed the actinides
  3. 3

    Anne Fellinger and Soraya Boudia (Charles Scribner's Sons, on Encyclopedia.com), 2008. Perey, Marguerite Catherine, in the Complete Dictionary of Scientific Biography .

    Perey's work on actinium sources at the Institut du Radium, and her contamination with actinium.

    • In 1934 the scientist, placing her confidence in Perey, asked her to prepare the most concentrated actiniferous sample ever prepared
    • At the end of 1938, she realized that this was due to an unknown radioactive substance formed from actinium
  4. 4

    Radchenko V. et al., Journal of Nuclear Medicine 62(11), 2021. Production and Supply of α-Particle–Emitting Radionuclides for Targeted α-Therapy , Sections 227Th/223Ra and 225Ac/213Bi.

    Production routes for actinium-225 and actinium-227, thorium-229 stocks by holder, world output of actinium-225, uses and supply limits.

    • There was virtually no production of 227 Ac between the 1970s and the past decade.
    • The supply of 225 Ra or 225 Ac from CERN-MEDICIS ... or Institute for Transuranium Elements, Karlsruhe, will become available for researchers through a newly approved coordinated European hub, PRISMAP ... The European medical isotope program kicked off in 2021
  5. 5

    Shannon Brescher Shea, US Department of Energy, Office of Science, 2018. The Journey of Actinium-225: How Scientists Discovered a New Way to Produce a Rare Medical Radioisotope .

    History of actinium-225 at Oak Ridge, the accelerator route, demand estimate, why alpha emitters treat cancer.

    • In the 1960s, scientists at the DOE’s Hanford Site produced uranium-233 as a fuel for nuclear weapons and reactors.
    • Those targets also contained thorium-229, which decays into actinium-225.
    • In 1994, a team from ORNL led by Mirzadeh started extracting thorium-229 from the target material.
    • In August 1997, they made their first shipment of actinium-225 to the National Cancer Institute.
  6. 6

    US Department of Energy, Office of Science, Isotope R&D and Production, 2019. Improving Isotope Supply for a Cancer-Fighting Drug .

    Actinium-227 made at Oak Ridge from recovered radium-226 for Bayer's radium-223 drug, under a 10-year contract.

    • After the Food and Drug Administration approved this new drug to treat prostate cancer in 2013, it was clear more actinium would be needed.
    • through a 10-year contract between the DOE Isotope Program and this firm, ORNL is producing actinium-227
  7. 7

    Kratochwil C. et al., Journal of Nuclear Medicine 57(12), 2016. 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer .

    The first patients treated with actinium-225-PSMA-617 in Heidelberg, and why some patients need an alternative to lutetium-177.

    • Recently, we started the first-in-human treatment with an α-radionuclide–labeled PSMA ligand.
  8. 8

    National Isotope Development Center, US Department of Energy Isotope Program, 2018. Isotope Routinely Available: Actinium-225 .

    Start of regular accelerator production in 2018, the Oak Ridge thorium-229 source, and ordering by quote.

    • Starting in February 2018, Ac-225 will be produced regularly via the proton bombardment of thorium-232 (Th-232) targets
  9. 9

    World Nuclear News, 2019. Partnership to produce medical isotope from legacy waste .

    The 2019 agreement between Isotek, TerraPower and the US DOE on thorium-229 from uranium-233.

    • Isotek will extract thorium-229 (Th-229) from the U-233, which TerraPower will then use for the production of Ac-225.
  10. 10

    National Isotope Development Center, US Department of Energy Isotope Program, 2025. Groundbreaking Cancer Therapy Clinical Trial with U.S. Department of Energy's Accelerator-Produced Actinium-225 Set to Begin this Summer .

    First clinical trial with accelerator-made actinium-225, June 2025.

    • will be the first to rely on accelerator-produced Ac-225 for human patient care
  11. 11

    Isonics Corporation, filed with the US Securities and Exchange Commission, 2005. Contract No. 840/08624390 between SSC RF - IPPE and Isonics Corporation (Exhibit 10.1) , Sections 1 and 2, Supplements 1 and 2.

    Contract price of actinium-225 sold by the Russian Institute for Physics and Power Engineering to a US company, and its specific activity.

    • The Seller has sold and the Buyer has bought Actinium-225 isotope ... Price per mCi/ US dollars ... 800.00
  12. 12

    International Atomic Energy Agency, 2019. IAEA Annual Report 2018 (GC(63)/5), Radioisotope Production and Radiation Technology .

    The 2018 technical meeting on the supply of actinium-225 and the three main production routes.

    • The meeting, held in Vienna in October, was attended by 70 participants from 17 Member States.
  13. 13

    Bristol Myers Squibb, 2024. Bristol Myers Squibb Completes Acquisition of RayzeBio, Adding Differentiated Actinium-Based Radiopharmaceutical Platform .

    The purchase price of RayzeBio and its lead actinium-225 drug candidate. Read with Firecrawl.

    • for a purchase price of $62.50 per share in cash, or approximately $4.1 billion
  14. 14

    AstraZeneca, 2024. Acquisition of Fusion completed .

    The purchase of Fusion Pharmaceuticals and its actinium-based drug candidates.

    • represent a transaction value of approximately $2.4bn
  15. 15

    World Nuclear News, 2024. TerraPower producing Ac-225 in commercial quantities .

    TerraPower Isotopes' announcement of commercial-scale production of actinium-225.

    • TerraPower Isotopes announced it is producing actinium-225 at commercial scale.
  16. 16

    Novartis, 2026. A Phase III, Open-label, Multi-center, Randomized Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive Metastatic Castration Resistant Prostate Cancer (NCT06855277) .

    The Phase 3 trial of actinium-225-PSMA-617, start date and status.

    • This is a phase III, open label, multicenter randomized study. ... Start Date Jul 01, 2025